Home > Cashflow Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Cash Flow from Financing Activities

    Back to Cashflow Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for EMCURE PHARMACEUTICALS
Please provide your vote to see the results

EMCURE PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Cash Flow from Financing Activities ₹-814 Cr₹-164 Cr₹-145 Cr₹-152 Cr₹-189 Cr

What is the latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS ?

The latest Cash Flow from Financing Activities ratio of EMCURE PHARMACEUTICALS is ₹-814 Cr based on Mar2025 Consolidated results.
Year Cash Flow from Financing Activities
Mar2025₹-814 Cr
Mar2024₹-164 Cr
Mar2023₹-145 Cr
Mar2022₹-152 Cr
Mar2021₹-189 Cr

How is Cash Flow from Financing Activities of EMCURE PHARMACEUTICALS Trending?

Years Cash Flow from Financing Activities % Change
Mar2025 ₹-814 Cr
Negative
Mar2024 ₹-164 Cr
Negative
Mar2023 ₹-145 Cr
Negative
Mar2022 ₹-152 Cr
Negative
Mar2021 ₹-189 Cr -

Compare Cash Flow from Financing Activities of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,249.3 Cr 7% 0.1% 59.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹432,000.0 Cr 1.5% 6.9% 13.1% Stock Analytics
DIVIS LABORATORIES ₹161,076.0 Cr -0.8% 1.7% 14% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,510.0 Cr 3.2% 9% 44.8% Stock Analytics
DR REDDYS LABORATORIES ₹107,921.0 Cr 1.1% 5% 16.4% Stock Analytics
CIPLA ₹106,150.0 Cr 0.3% -1.3% -9% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

7%

0.1%

59.1%

SENSEX

-5.5%

-11.5%

0.3%


You may also like the below Video Courses